Liz Christie
@drlizchristie.bsky.social
Group Leader at Peter MacCallum Cancer Centre
DoD Ovarian Cancer Academy
Ovarian & Endometrial Cancer | Treatment Resistance
Cancer Genomics | Bioinformatics
DoD Ovarian Cancer Academy
Ovarian & Endometrial Cancer | Treatment Resistance
Cancer Genomics | Bioinformatics
Reposted by Liz Christie
🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz
August 11, 2025 at 4:48 PM
🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz
Reposted by Liz Christie
Single-cell analysis reveals the extent of genome doubling in ovarian cancer, its variability and its role in enabling tumours to evade the immune system
go.nature.com/4kJLAjZ
go.nature.com/4kJLAjZ
Genome doubling fuels ovarian cancer evolution and immune dysregulation
Single-cell analysis reveals the extent of genome doubling in ovarian cancer, its variability and its role in enabling tumours to evade the immune system.
go.nature.com
July 17, 2025 at 8:14 AM
Single-cell analysis reveals the extent of genome doubling in ovarian cancer, its variability and its role in enabling tumours to evade the immune system
go.nature.com/4kJLAjZ
go.nature.com/4kJLAjZ
Reposted by Liz Christie
Today kicks off a major campaign by ANZGOG to highlight how common and impactful gynecological cancers are, even though each type individually is rare. #oncosky #cansky www.abc.net.au/news/2025-04...
Poor investment in gynaecological cancer research leading to 'crisis for women', experts warn - ABC News
A new report has found gynaecological cancers have been among the poorest funded for almost two decades — these women hope to change that.
www.abc.net.au
April 13, 2025 at 1:47 AM
Today kicks off a major campaign by ANZGOG to highlight how common and impactful gynecological cancers are, even though each type individually is rare. #oncosky #cansky www.abc.net.au/news/2025-04...
Reposted by Liz Christie
🚨Scoop: Keynote speakers announced for the Australasian Genomic Technologies Association #AGTA25 Annual Conference #genomics #Sydney #Australia
April 9, 2025 at 4:22 AM
🚨Scoop: Keynote speakers announced for the Australasian Genomic Technologies Association #AGTA25 Annual Conference #genomics #Sydney #Australia
Reposted by Liz Christie
We are recruiting a group leader in laboratory research at Peter Mac Cancer Centre in
Melbourne, Australia 🔬🦘💥
Work in a cutting edge research environment in a vibrant world city!
We value research excellence, creativity and diversity.
Join us!
careers.petermac.org/job/MELBOURN...
Melbourne, Australia 🔬🦘💥
Work in a cutting edge research environment in a vibrant world city!
We value research excellence, creativity and diversity.
Join us!
careers.petermac.org/job/MELBOURN...
Group Leader
Group Leader
careers.petermac.org
March 5, 2025 at 8:04 AM
We are recruiting a group leader in laboratory research at Peter Mac Cancer Centre in
Melbourne, Australia 🔬🦘💥
Work in a cutting edge research environment in a vibrant world city!
We value research excellence, creativity and diversity.
Join us!
careers.petermac.org/job/MELBOURN...
Melbourne, Australia 🔬🦘💥
Work in a cutting edge research environment in a vibrant world city!
We value research excellence, creativity and diversity.
Join us!
careers.petermac.org/job/MELBOURN...
It was an honor to be awarded the Peter Mac Sambrook Prize in 2024 with Nikki Burdett for our work in Nature Genetics examining treatment resistance in ovarian cancer rdcu.be/d2kOC
December 4, 2024 at 3:49 AM
It was an honor to be awarded the Peter Mac Sambrook Prize in 2024 with Nikki Burdett for our work in Nature Genetics examining treatment resistance in ovarian cancer rdcu.be/d2kOC